Icosagen

Icosagen is a leading Contract Research, Development, and Manufacturing Organisation (CRDMO), providing comprehensive 'Gene-to-GMP' services for the biotechnology and pharmaceutical sectors. The company specialises in the development and production of biologics, guiding partners from initial concept to clinical supply. Their fully integrated platform covers antibody discovery, protein engineering, proprietary cell line development, and process optimisation, all culminating in certified GMP manufacturing. By offering end-to-end solutions under one roof, Icosagen accelerates therapeutic development timelines, enabling clients to bring innovative medicines to patients more efficiently and reliably.

Icosagen’s technology platform offers a fully integrated solution for biologics development. It begins with advanced antibody discovery and engineering, ensuring optimal developability from the outset. This transitions seamlessly into their proprietary IcoCell® platform for rapid, high-yield CHO cell line development. The end-to-end service includes robust protein production, meticulous process development, and scalable GMP manufacturing for clinical supply. By combining these capabilities, the platform is engineered to de-risk projects, ensure consistency from gene to product, and significantly shorten the timeline from laboratory research to certified clinical manufacturing.